Mannitol osmotherapy
Indication-specific bolus and follow-up CRI calculator for mannitol, aligned with Plumb's: osmotic diuresis, oliguric acute kidney injury (with optional 60–120 mg/kg/hr maintenance CRI), acute glaucoma, increased intracranial pressure from cerebral edema (no CRI), and adjunctive treatment of uroliths (with fixed 1 mg/kg/min maintenance CRI). Computes total dose, volume at 20% or 25% concentration, pump rate for the bolus, and mL/hr for any maintenance CRI. Surfaces the 2 g/kg/24h cumulative ceiling and the crystallization-filter requirement.
Mannitol is given as a 15–30 min infusion, repeated up to q4–6h for cerebral edema or as a single response-test dose for oliguric AKI. The pump rate computed here is for the brief infusion window only, not for hours of sustained delivery. Cumulative dosing above 2 g/kg/24h has been associated with paradoxical worsening of cerebral edema (reverse osmotic shift) and acute kidney injury (osmotic nephrosis).
Enter patient weight, dose, and infusion duration to see the result.
Formula
Total mannitol dose is a simple weight-by-dose product. Volume follows from the chosen stock concentration; pump rate divides volume by the infusion window.
Stock conversions: 20% mannitol = 0.20 g/mL; 25% mannitol = 0.25 g/mL.
Dose ranges by indication (per Plumb's)
| Indication | Bolus dose | Duration | Repeat / CRI |
|---|---|---|---|
| Osmotic diuresis (label) | 1.5–2 g/kg | 30 min | Single dose |
| Oliguric AKI | 0.25–1 g/kg | 15–20 min | q4–6h OR CRI 60–120 mg/kg/hr; cap 2 g/kg/day |
| Acute glaucoma (IOP) | 1–2 g/kg | 10–20 min | Single dose; limit water intake 1–4 hr post-dose |
| Increased ICP / cerebral edema | 0.5–1 g/kg | 15–20 min | q6–8h boluses; CRI NOT recommended |
| Uroliths | 0.25–0.5 g/kg loading | 20 min | Then CRI at 1 mg/kg/min (= 60 mg/kg/hr) |
Cumulative-dose ceiling
Sustained or high cumulative dosing produces two distinct paradoxical effects. In the brain, prolonged exposure allows mannitol to cross the disrupted blood-brain barrier; once inside the brain, it draws water back across by reverse osmotic shift, worsening cerebral edema. In the kidney, accumulation of mannitol in the proximal tubule produces osmotic nephrosis (vacuolation, swelling, tubular dysfunction) that mimics or worsens existing AKI.
The conventional ceiling is 2 g/kg/24h, or sustained therapy beyond 5–7 days. Serum osmolality monitoring (target <320 mOsm/kg) provides an empirical safety check that supersedes the strict cumulative dose limit.
Source citations
- Plumb DC. Plumb's Veterinary Drugs. Mannitol monograph (current edition). Indication-specific dose ranges and the cumulative ceiling derive from this monograph.
- Silverstein DC, Hopper K, eds. Small Animal Critical Care Medicine. 4th ed. St. Louis, MO: Elsevier; 2023. Ch. 88 (Traumatic Brain Injury); Ch. 117 (Acute Kidney Injury).
- DiBartola SP, ed. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice. 4th ed. St. Louis, MO: Elsevier Saunders; 2012. Ch. 26 (Acute Kidney Injury). Mechanism, osmotic nephrosis, and serum osmolality monitoring target.